This funding opportunity encourages research to develop novel screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. It also supports work on high priority genetic conditions where screening may soon be possible. The focus is on accurate screening tests and demonstrating benefits of early intervention or treatment to improve newborn health outcomes.
Eligible applicants include a wide range of institutions such as public and private higher education institutions, government entities, nonprofits, small businesses, tribal organizations, and certain federal agencies and regional organizations.
